Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives Article

Runnebaum, IB, Wang-Gohrke, S, Vesprini, D et al. (2001). Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives . 11(7), 635-638. 10.1097/00008571-200110000-00010

International Collaboration

cited authors

  • Runnebaum, IB; Wang-Gohrke, S; Vesprini, D; Kreienberg, R; Lynch, H; Moslehi, R; Ghadirian, P; Weber, B; Godwin, AK; Risch, H; Garber, J; Lerman, C; Olopade, OI; Foulkes, WD; Karlan, B; Warner, E; Rosen, B; Rebbeck, T; Tonin, P; Dube, MP; Kieback, DG; Narod, SA

sustainable development goals

authors

publication date

  • October 1, 2001

keywords

  • BREAST-CANCER
  • Biotechnology & Applied Microbiology
  • GENE
  • Genetics & Heredity
  • Life Sciences & Biomedicine
  • POLYMORPHISM
  • Pharmacology & Pharmacy
  • REPEAT
  • Science & Technology
  • hereditary breast cancer
  • hereditary ovarian cancer
  • oral contraception
  • progesterone receptor

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 635

end page

  • 638

volume

  • 11

issue

  • 7